TCMBANKIN011831 |
salicin |
Spectrum5_000971; (2S,3S,4R,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol; AI3-19099; NCGC00142605-01; Saligenin-beta-D-glucopyranoside; D-(−)-Salicin; B-D-Glucopyranoside, 2-(hydroxymethyl)phenyl; Spectrum4_001058; Spectrum3_000948; MEGxp0_000685; SDCCGMLS-0066698.P001; 2-(Hydroxymethyl)phenyl-beta-D-glucopyranoside; ZINC155886; Salicoside; KBio3_002016; (2R,3S,4S,5R,6S)-2-methylol-6-(2-methylolphenoxy)tetrahydropyran-3,4,5-triol; beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl; KBio1_000030; Spectrum_001230; EINECS 205-331-6; Spectrum2_000756; 2-(Hydroxymethyl)phenyl beta-D-glucopyranoside; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol; DivK1c_000030; o-(Hydroxymethyl)phenyl beta-D-glucopyranoside; AC1OC2WD; KBioGR_001356; CHEBI:17814; KBio2_006846; SBB012498; IDI1_000030; 138-52-3; 30370-90-2; Saligenin beta-D-glucopyranoside; SPECTRUM1502255; SPBio_000772; 2-(hydroxymethyl)phenyl-beta-D-glucoside; NSC 5751; 2(hydroxymethyl)phenyl-beta-D-glucopyranoside; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]tetrahydropyran-3,4,5-triol; ZINC03847505; C01451; S0625_SIGMA; alpha-Hydroxy-o-tolyl beta-D-glucopyranoside; Salicin (6CI,8CI); KBio2_001710; KBio2_004278; NINDS_000030; KBioSS_001710; ACon1_000373 |
C13H18O7 |
286.28 |
C1=CC=C(C(=C1)CO)OC2C(C(C(C(O2)CO)O)O)O |